Company Search:
Advanced Search
Sponsored Links
Bausch Health Companies Inc Company Snapshot
Bausch Health Companies Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bausch Health Companies Inc with three other pharmaceutical manufacturers in North America: Vertex Pharmaceuticals Inc of UNITED STATES (2020 sales of $6.21 billion of which 62% was TRIKAFTA), Zoetis Inc of UNITED STATES ($6.68 billion of which 53% was US), and Regeneron Pharmaceuticals Incorporated which is also based in UNITED STATES ($8.50 billion of which 58% was EYLEA).

Sales Analysis. During the second quarter of 2021, sales at Bausch Health Companies Inc totalled C$2.57 billion. This is an increase of 15.4% from the C$2.23 billion in sales at the company during the second quarter of 2020. This was the largest same quarter increase in sales since the fourth quarter of 2015. During the first two quarters of 2021, sales totalled C$5.14 billion, which is 4.5% higher than through the first two quarters of 2020. During the year ended December of 2020, sales at Bausch Health Companies Inc were C$10.75 billion (US$8.47 billion). This is a decrease of 5.5% versus 2019, when the company's sales were C$11.38 billion. Contributing to the drop in overall sales was the 7.8% decline in U.S. Diversified Products Segment, from C$1.69 billion to C$1.56 billion. There were also decreases in sales in Bausch and Lomb / International Segment (down 5.9% to C$5.90 billion) and Salix (down 4.7% to C$2.55 billion) and Ortho Dermatologics (down 0.9% to C$740.58 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Bausch Health Companies Inc
  Stock Performance Chart for Bausch Health Companies Inc
  Stock Data: Recent Stock Performance:
  Current Price (9/24/2021): 36.51
(Figures in Canadian Dollars)
1 Week 5.0%   13 Weeks -0.1%  
4 Weeks -0.7%   52 Weeks 78.2%  
Bausch Health Companies Inc Key Data:
  Ticker: BHC Country: Canada
  Exchanges: NYSE TOR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 10,749,838,670
(Year Ending Jan 2021).
Employees: 21,600
  Currency: Canadian Dollars Market Cap: 13,094,453,852
  Fiscal Yr Ends: December Shares Outstanding: 358,653,899
  Share Type: Common Closely Held Shares: 15,772,809
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.